Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his new column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Advanced Cell Technology (OTCBB:ACTC) has received approval to move forward with enrolling and treating the next set of patients.
As OneMedForum SF 2012 approaches, OneMedSentinel is on the lookout for some of the most promising companies and technologies, as well as innovative approaches to […]
OneMedPlace announced today that OneMedForum San Francisco 2012 will feature special reports in 8 healthcare sectors.
“We have very clear timelines, milestones, and we define the critical experiment that, if it’s successful will bring value to the technology and make it ready for follow-up funding.”
With the recent acquisition of the two Chinese companies, restructuring, and the addition of a new CFO, Vasomedical is now positioned to move forward and further implement plans for expansion and growth.
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his new column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
NeoStem has transformed itself over the last year and half with two acquisitions, multiple financings and their expansion into China.
Citigroup [NYSE:CITI] pricing GSVC’s $100 million raise this week. As of end of trading Sept 19th, GSVC stock is trading at about $14.37 and seems undervalued for several reasons.
OneMedSentinel is pleased to bring you another round of stories and interviews with some of the most promising companies and technologies, as well as innovative […]
Copyright © 2024 | WordPress Theme by MH Themes